Enlitic, a San Francisco, CA-based deep learning medical startup, raised a $10M Series B funding round.
The round was led by Capitol Health Limited (ASX: CAJ), a large radiology service provider in Australia. The two companies have also announced a global partnership to bring deep learning-supported diagnostics to the Australian and Asian healthcare markets.
The company will use the funds to expand the use cases of its platform and map the entire human body and its afflictions.
Led by CEO data scientist Jeremy Howard, Enlitic is a deep learning company dedicated to improve diagnostic healthcare. Its existing tools, which span a wide range of ailments, from lung cancer to bone fractures, are commercially integrated end-to-end, and will power hundreds of radiologists’ workflow across Capitol Health’s large-scale care network.
The company leverages Capitol’s image archives across all radiology modalities (Ultrasound, CT, MRI, PET, X-Ray) to accelerate training of deep learning algorithms, and to support diagnosis of thousands of diseases and afflictions.
Mission and Market, a seed fund based in San Francisco, also participated in the round.